StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix cash

Cash and short-term investments held at the end of each period.

CorMedix's cash was $256.69M at Jun 30, 2026. For fiscal 2025 it was $148.53M, up 186.8% from the year before. Over ten years it grew 15.4% a year on average. The highest annual figure on record is $148.53M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$148.53M+186.8%
FY2024Dec 31, 2024$51.79M-32.0%
FY2023Dec 31, 2023$76.21M+29.1%
FY2022Dec 31, 2022$59.02M-10.2%
FY2021Dec 31, 2021$65.70M+41.2%
FY2020Dec 31, 2020$46.54M+63.2%
FY2019Dec 31, 2019$28.51M+60.2%
FY2018Dec 31, 2018$17.80M+46.4%
FY2017Dec 31, 2017$12.16M-40.2%
FY2016Dec 31, 2016$20.34M-42.5%
FY2015Dec 31, 2015$35.39M+715.4%
FY2014Dec 31, 2014$4.34M+82.8%
FY2013Dec 31, 2013$2.37M+184.1%
FY2012Dec 31, 2012$835.47K-57.9%
FY2011Dec 31, 2011$1.99M-76.0%
FY2010Dec 31, 2010$8.28M+450.3%
FY2009Dec 31, 2009$1.51M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$256.69M+34.6%
Q1 FY2026Mar 31, 2026$178.09M+129.8%
Q4 FY2025Dec 31, 2025$148.53M+186.8%
Q3 FY2025Sep 30, 2025$55.72M+21.0%
Q2 FY2025Jun 30, 2025$190.71M+318.1%
Q1 FY2025Mar 31, 2025$77.50M+32.4%
Q4 FY2024Dec 31, 2024$51.79M-32.0%
Q3 FY2024Sep 30, 2024$46.03M-46.8%
Q2 FY2024Jun 30, 2024$45.61M-13.0%
Q1 FY2024Mar 31, 2024$58.55M+5.3%
Q4 FY2023Dec 31, 2023$76.21M+29.1%
Q3 FY2023Sep 30, 2023$86.59M+46.8%
Q2 FY2023Jun 30, 2023$52.40M-19.2%
Q1 FY2023Mar 31, 2023$55.60M-10.2%
Q4 FY2022Dec 31, 2022$59.02M-10.2%
Q3 FY2022Sep 30, 2022$59.00M-18.3%
Q2 FY2022Jun 30, 2022$64.85M-17.4%
Q1 FY2022Mar 31, 2022$61.92M-23.9%
Q4 FY2021Dec 31, 2021$65.70M+41.2%
Q3 FY2021Sep 30, 2021$72.21M+94.0%
Q2 FY2021Jun 30, 2021$78.49M+247.0%
Q1 FY2021Mar 31, 2021$81.41M+248.5%
Q4 FY2020Dec 31, 2020$46.54M+63.2%
Q3 FY2020Sep 30, 2020$37.22M+14.1%
Q2 FY2020Jun 30, 2020$22.62M-14.8%
Q1 FY2020Mar 31, 2020$23.36M-11.4%
Q4 FY2019Dec 31, 2019$28.51M+60.2%
Q3 FY2019Sep 30, 2019$32.61M+392.9%
Q2 FY2019Jun 30, 2019$26.56M+444.9%
Q1 FY2019Mar 31, 2019$26.37M+216.5%
Q4 FY2018Dec 31, 2018$17.80M+46.4%
Q3 FY2018Sep 30, 2018$6.62M-45.7%
Q2 FY2018Jun 30, 2018$4.87M-74.3%
Q1 FY2018Mar 31, 2018$8.33M-40.2%
Q4 FY2017Dec 31, 2017$12.16M-40.2%
Q3 FY2017Sep 30, 2017$12.18M-54.3%
Q2 FY2017Jun 30, 2017$18.99M–
Q1 FY2017Mar 31, 2017$13.94M–
Q4 FY2016Dec 31, 2016$20.34M–
Q3 FY2016Sep 30, 2016$26.65M–

More CorMedix figures

See a number that looks wrong?